Book chapter · 2026 · Open access
TRANSLATIONAL AND REGULATORY CHALLENGES IN THE DEVELOPMENT OF NANOMEDICINE-ENABLED DRUG DELIVERY DEVICES
Zenodo (CERN European Organization for Nuclear Research) · Published 15 January 2026 · DOI 10.5281/zenodo.18261916
In brief
“TRANSLATIONAL AND REGULATORY CHALLENGES IN THE DEVELOPMENT OF NANOMEDICINE-ENABLED DRUG DELIVERY DEVICES” is a 2026 book chapter by Nihar Ranjan Sahoo*, Amiya Kanta Mishra, Amandeep Singh, Shonak Sandeep Adivarekar, published in Zenodo (CERN European Organization for Nuclear Research). OpenAlex counts 0 citations as of 20 November 2026. It is open access under a CC BY licence: the full text is free to read at Zenodo (CERN European Organization for Nuclear Research).
- Citations
- 0
- Authors
- 1
Abstract
Nanomedicine-enabled drug delivery devices have emerged as a transformative platform in modern therapeutics, offering enhanced targeting, improved bioavailability, and personalized treatment strategies across multiple disease areas. Despite their immense clinical potential, the translation of nanomedicine-based systems from laboratory research to approved medical products remains a formidable challenge due to their complex physicochemical behavior, manufacturing variability, and evolving regulatory expectations. This review critically examines the major translational and regulatory barriers affecting the development of nanomedicine-enabled drug delivery devices. Key scientific issues such as nanomaterial heterogeneity, unpredictable in vivo performance, scalability, and reproducibility are discussed alongside the limitations of existing preclinical models in predicting human outcomes. Furthermore, the review highlights the regulatory complexities arising from the hybrid nature of these products, which often fall between traditional drug, device, and biologic classifications, leading to fragmented and non-harmonized global regulatory pathways. Strategies to address these challenges—including standardized characterization methods, adaptive regulatory frameworks, advanced manufacturing technologies, and early regulatory engagement—are explored. By identifying critical gaps and proposing future-oriented solutions, this review provides a comprehensive roadmap to facilitate the safe, efficient, and timely translation of nanomedicine-enabled drug delivery devices into clinical practice.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Adivarekar, N. R. S. A. K. M. A. S. S. S. (2026). TRANSLATIONAL AND REGULATORY CHALLENGES IN THE DEVELOPMENT OF NANOMEDICINE-ENABLED DRUG DELIVERY DEVICES. Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.18261916
MLA 9
Adivarekar, Nihar Ranjan Sahoo*, Amiya Kanta Mishra, Amandeep Singh, Shonak Sandeep. “TRANSLATIONAL AND REGULATORY CHALLENGES IN THE DEVELOPMENT OF NANOMEDICINE-ENABLED DRUG DELIVERY DEVICES.” Zenodo (CERN European Organization for Nuclear Research), 2026. https://doi.org/10.5281/zenodo.18261916.
Chicago
Adivarekar, Nihar Ranjan Sahoo*, Amiya Kanta Mishra, Amandeep Singh, Shonak Sandeep. 2026. “TRANSLATIONAL AND REGULATORY CHALLENGES IN THE DEVELOPMENT OF NANOMEDICINE-ENABLED DRUG DELIVERY DEVICES.” Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.18261916.
Harvard
Adivarekar, N. R. S. A. K. M. A. S. S. S. (2026) ‘TRANSLATIONAL AND REGULATORY CHALLENGES IN THE DEVELOPMENT OF NANOMEDICINE-ENABLED DRUG DELIVERY DEVICES’, Zenodo (CERN European Organization for Nuclear Research). doi:10.5281/zenodo.18261916.
IEEE
N. R. S. A. K. M. A. S. S. S. Adivarekar, “TRANSLATIONAL AND REGULATORY CHALLENGES IN THE DEVELOPMENT OF NANOMEDICINE-ENABLED DRUG DELIVERY DEVICES,” Zenodo (CERN European Organization for Nuclear Research), 2026, doi: 10.5281/zenodo.18261916.
BibTeX
@incollection{adivarekar2026translational,
title = {{TRANSLATIONAL AND REGULATORY CHALLENGES IN THE DEVELOPMENT OF NANOMEDICINE-ENABLED DRUG DELIVERY DEVICES}},
author = {Adivarekar, Nihar Ranjan Sahoo*, Amiya Kanta Mishra, Amandeep Singh, Shonak Sandeep},
booktitle = {Zenodo (CERN European Organization for Nuclear Research)},
publisher = {European Organization for Nuclear Research},
year = {2026},
doi = {10.5281/zenodo.18261916},
url = {https://doi.org/10.5281/zenodo.18261916}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- nanomedicine
- drug delivery devices
- translational barriers
- regulatory challenges
- manufacturing variability
- preclinical models
- regulatory classification
- regulatory harmonization
Work with this paper
Most-cited papers in Materials Science
- Electric Field Effect in Atomically Thin Carbon FilmsKostya S. Novoselov, Andre K. Geim, Sergey V. Morozov and 5 more · Science · 2004 · 67,474 citations
- Revised effective ionic radii and systematic studies of interatomic distances in halides and chalcogenidesROBERT D. SHANNON · Acta Crystallographica Section A · 1976 · 66,944 citations
- Ab initio molecular dynamics for liquid metalsGeorg Kresse, J. Häfner · Physical review. B, Condensed matter · 1993 · 46,320 citations
- Helical microtubules of graphitic carbonSumio Iijima · Nature · 1991 · 43,639 citations
- The rise of grapheneAndre K. Geim, Kostya S. Novoselov · Nature Materials · 2007 · 40,328 citations
Questions about this paper
How do I cite this paper in APA style?
Adivarekar, N. R. S. A. K. M. A. S. S. S. (2026). TRANSLATIONAL AND REGULATORY CHALLENGES IN THE DEVELOPMENT OF NANOMEDICINE-ENABLED DRUG DELIVERY DEVICES. Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.18261916
How many times has this paper been cited?
0 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Zenodo (CERN European Organization for Nuclear Research): sign in and open the full text from this page.
Who wrote this paper?
Nihar Ranjan Sahoo*, Amiya Kanta Mishra, Amandeep Singh, Shonak Sandeep Adivarekar.
What is the DOI of this paper?
10.5281/zenodo.18261916, permanently at https://doi.org/10.5281/zenodo.18261916. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.